Form D · Biotechnology
Medical Nutrition Innovation, Inc.
Exton, PA · CIK 0001765671
Offering snapshot reported Feb 21, 2019 · SEC filing
- Reported sold
- $1.25M Offering amount: $4.67M
- Investors reported
- 32 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 15, 2019 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$941,304 → $1,250,000
- Reported investors29 → 32
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2019 | Amendment | $1,250,000 | $308,696vs Jan 30, 2019 | 32 | SEC filing |
| Jan 30, 2019 | Initial | $941,304 | No comparison | 29 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-331704
Source: Form D, filed Feb 21, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Gravina | Director |
| Frederick Jones | Director |
| James O'connell | Director, Executive |
| Virginia Stallings | Director |
| Richard Vague | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
256 Eagleview Blvd #213
Exton, PA, 19341
Exton, PA, 19341